Deep vein thrombosis: Epidemiology, risk factors and natural history;La thrombose veineuse profonde: Épidémiologie, facteurs de risque et évolution naturelle

Praxis

Volumn 95, Issue 12, 2006, Pages 455-459

  Coiteux, I ^a   Mazzolai, Lucia ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Deep vein thrombosis; Incidence; Risk factor

Indexed keywords

EID: 33645658334     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: 10.1024/0369-8394.95.12.455     Document Type: Review

References (42)

1. Gray HW. The natural history of evnous thromboembolism: impact on ventilation/perfusion scan reporting. Semin Nucl Med 2002; 32: 159-172. (Pubitemid 34803589)
2. Cruick shank MK, Levine MN, Hirsh J, et al. An evaluation of impedance plethysmography and 125I-fibrinogen leg scanning in patients following hip surgery. Thromb Haemost 1989; 62: 830-834.
3. Ridker PM, Miletich JP, Hennekens CH, Buring JE. Ethnic distribution of afctor V Leiden in 4047 men and women. Implica tions for venous thromboembolism screening. JAMA 1997; 277: 1305-1307. (Pubitemid 27194355)
4. Anderson FA Jr, Wheeler HB, Goldberg RJ, Hosmer DW, Forcier A, Patwardhan NA. Physician practices in the prevention of venous thromboembolism. Ann Intern Med 1991; 115: 591-595.
5. Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 1991; 151: 933-938.
6. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ, III. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population- based study. Arch Intern Med 1998;158: 585-593. (Pubitemid 28144815)
7. Wroblewski BM, Siney P, White R. Seasonal variation in fatal pulmonary embolism after hip arthroplasty. Lancet 1990; 335: 56. (Pubitemid 20020471)
8. Bounameaux H, Hicklin L, Desmarais S. Seasonal variation in deep vein thrombosis. BMJ 1996; 312: 284-285. (Pubitemid 26040805)
9. Boulay F, Berthier F, Schoukroun G, Raybaut C, Gendreike Y, Blaive B. Seasonal variations in hospital admission for deep vein thrombosis and pulmonary embolism: analysis of discharge data. BMJ 2001;323: 601-602. (Pubitemid 32846127)
10. Sorensen HT, Mellemkjaer L, Olsen JH, Baron JA. Pr ognosis of cancers associated with venous thromboembolism. N Engl J Med 2000; 343: 1846-1850. (Pubitemid 32104130)
11. Prandoni P, Lensing AW, Piccioli A, et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 2002; 100: 3484-3488. (Pubitemid 35303914)
12. Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Polak JF, Folsom AR. Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch Intern Med 2002; 162: 1182-1189. (Pubitemid 34522408)
13. Saarinen J, Laurikka J, Sisto T, Tarkka M, Hakama M. The incidence and cardiovascular risk indicators of deep venous thrombosis. Vasa 1999; 28: 195-198. (Pubitemid 29378739)
14. Goldhaber SZ, Savage DD, Garrison RJ, et al. Risk factors for pulmonary embolism. The Framingham Study. Am J Med 1983;74: 1023-1028. (Pubitemid 13101585)
15. Goldhaber SZ, Grodstein F, Stampfer MJ, et al. A prospective study of risk factors for pulmonary embolism in women. JAMA 1997; 277: 642-645. (Pubitemid 27097428)
16. Hansson PO, Eriksson H, Welin L, Svardsudd K, Wilhelmsen L. Smoking and abdominal obesity: risk factors for venous thromboembolism among middle-aged men:"the study of men born in 191. A3"r ch Intern Med 1999; 159: 1886-1890. (Pubitemid 29424708)
17. Zoller B, Garcia dF, Dahlback B. Evaluation oft he erlationship between protein S and C4b-binding protein isoforms in hereditary protein S deficiency demonstrating type I and type III deficiencies to be phenotypic variants of the same genetic disease. Blood 1995; 85: 3524-3531.
18. Engesser L, Broekmans AW, Briet E, Brommer EJ, Bertina RM. Hereditary protein S deficiency: clinical manifestations. Ann Intern Med 1987; 106: 677-682. (Pubitemid 17067983)
19. Mar tinelli I, Mannucci PM, De SV, et al. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families. Blood 1998; 92: 2353-2358.
20. Miletich J, Sherman L, Broze G, Jr. Absence of thrombosis in subjects with heterozygous protein C deficiency. N Engl J Med 1987;317: 991-996. (Pubitemid 17147955)
21. van der Meer J, FKoster T, Vandenbroucke PJ, Briet E, Rosendaal FR. The Leiden Thrombophilia Study (LETS). Thromb Haemost1997; 78: 631-635.
22. Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 1995; 85: 1504-1508.
23. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 19953;32: 912-917.
24. Nicolaides AN, Kakkar VV, Field ES, Renney JT. The origin of deep vein thrombosis: a venographic study. Br J Radiol 1971; 44: 653-663.
25. Kakkar VV, Howe CT, Flanc C, Clarke MB. Natural history of postoperative deep-vein thrombosis. Lancet 1969; 2: 230-232.
26. Maynard MJ, Sculco TP, Ghelman B. Progression and regression of deep vein thrombosis after total knee arthroplasty. Clin Orthop 1991; 125-130.
27. Kearon C. Natural history of venous thromboembolism. Circulation 2003; 107: 122-130.
28. Cogo A, Lensing AW, Prandoni P, Hirsh J. Distribution of thrombosis in patients with symptomatic deep vein thrombosis. Implications for simplifying the diagnostic process with compression ultrasound. Arch Intern Med 1993; 153: 2777-2780. (Pubitemid 24005653)
29. Kearon C, Julian JA, Newman TE, Ginsberg JS. Noninvasive diagnosis of deep venous thrombosis. McMaster Diagnostic Imaging Practice Guidelines Initiative. Ann Intern Med 1998;128: 663-677.
30. Lagerstedt CI, Olsson CG, Fagher BO, Oqvist BW, Albrechtsson U. Need for long-term anticoagulant treatment in symptomatic calfvein thrombosis. Lancet 1985; 2: 515-518. (Pubitemid 15236478)
31. Nielsen HK, Husted SE, Krusell LR, Fasting H, Charles P, Hansen HH. Silent pulmonary embolism in patients with deep venous thrombosis. Incidence and fate in a randomized, controlled trial of anticoagulation versus no anticoagulation. J Intern Med 1994;235: 457-461. (Pubitemid 24212811)
32. Moser KM, Fedullo PF, LitteJohn JK, Crawford R. Frequent asymptomatic pulmonary embolism in patients with deep venous thrombosis. JAMA 1994;271: 223-225. (Pubitemid 24041261)
33. Huisman MV, Buller HR, ten Cate JW, et al. Unexpected high pr evalence of silent pulmonary embolism in patients with deep venous thrombosis. Chest 1989; 95: 498-502. (Pubitemid 19094432)
34. Nielsen HK, Husted SE, Krusell LR,et al. Anticoagulant therapy in deep venous thrombosis. A randomized controlled study. Thromb Res 1994; 73: 215-226. (Pubitemid 24076307)
35. Hull R, Delmore T, Genton E, et al. Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis. N Engl J Med 1979; 301: 855-858. (Pubitemid 10165871)
36. Prandoni P, Lensing AW, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996;125:1-7.
37. Levine MN, Hirsh J, Gent M, Turpie AG, et al. Optimal duration of o ral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Thromb Haemost 1995; 74: 606-611.
38. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002; 346: 752-763. (Pubitemid 34983997)
39. Pinede L, Ninet J, Duhaut P, et al. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation 2001; 103: 2453-2460. (Pubitemid 32493371)
40. Prandoni P, Lensing AW, Prins MH,et al. Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism. Ann Intern Med 2002; 137: 955-960. (Pubitemid 35440241)
41. Douketis JD, Kearon C, Bates S, Duku EK, Ginsberg JS. Risk of aftal pulmonary embolism in patients with treated venous thromboembolism. JAMA 1998;279: 458-462. (Pubitemid 28082257)
42. Murin S, Romano PS, White RH. Comparison of outcomes after hospitalization for deep venous thrombosis or pulmonary embolism. Thromb Haemost 2002; 88: 407-414. (Pubitemid 35021597)